Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by newbie101abcon Oct 05, 2024 10:44am
29 Views
Post# 36254445

RE:RE:Reposted - may explain the large BID versus ASK

RE:RE:Reposted - may explain the large BID versus ASKThat is simple.  It is in the research agreement between USC Keck and Pfizer, including regulatory support and clinical trial support.   The NIH and especially the CDC are in a full blown panic unless you've been living in a cave and not realizing all of the viruses spreading around the globe.  Be it mpox, warburg in Africa, swine fever putting Italy's $30 billion CAD pork industry at risk,  or the spread of avian bird flu amongst the poulty and dairy farms in the U.S.   The NIH has a paper indicating the anti-viral properties found in cannabis for bird flu.   There is a massive panic going on because if not contained the U.S. won't be able to feed itself and there are over 15 cases of human infections, the latest being human to human transmission of avian bird flu.   "Cannabinoid availability in the U.S." as requested by the NIH and CDC is to find out do they have enough capacity because you can mix it in with the feed stock for livestock.   A quiet warning was already issued to duck and geese hunters not to come into contact with blood from birds that have been shot while hunting and the migratory season is now underway.   There are over 4 different virus outbreaks all over the globe.  Tigers in captivity in Vietnam all passed away from bird flu, bodies burned and burried onsite so it's not just dairy cows and humans.   

So read the research agreement between Pfizer and USC Keck and Pfizer has the rights to pursue clinical trials on any developements with their research partner USC Keck. 

It is a well established research partnership so why are you asking about news? 

 
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse